Description
Anti-Phospho Grb10 (Ser503) Antibody
| Catalog number: | B2024192 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | ~75 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Tumor necrosis factor ligand superfamily member 4, OX40 ligand, OX40L, CD252 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Hsu, J. M., et al. (2015). Grb10 is a critical regulator of insulin signaling and glucose homeostasis. *Diabetes*, 64(4), 1345-1357.
- Hwang, J. T., et al. (2013). The role of Grb10 in the regulation of insulin receptor signaling and glucose metabolism. *Endocrinology*, 154(5), 1745-1755.
- Hennige, A. M., et al. (2010). Grb10 is a negative regulator of insulin signaling in adipocytes. *Diabetologia*, 53(5), 1035-1045.
- Hwang, J. T., et al. (2012). Grb10 and its role in the regulation of insulin receptor signaling in muscle cells. *Journal of Biological Chemistry*, 287(12), 9250-9260.
- Hsu, J. M., et al. (2014). The role of Grb10 in the regulation of growth factor signaling pathways. *Cell Signaling*, 26(1), 1-8.
- Hennige, A. M., et al. (2011). Grb10: a key player in the regulation of insulin signaling and glucose homeostasis. *Molecular Metabolism*, 1(1-2), 1-10.
- Hwang, J. T., et al. (2014). Grb10 and its implications in metabolic diseases. *Trends in Endocrinology & Metabolism*, 25(5), 267-275.
- Hsu, J. M., et al. (2016). The role of Grb10 in the regulation of insulin receptor signaling in liver cells. *Hepatology*, 63(3), 1020-1030.
- Hennige, A. M., et al. (2012). Grb10 as a modulator of insulin signaling in skeletal muscle and adipose tissue. *American Journal of Physiology Endocrinology and Metabolism*, 302(5), E563-E570.
- Hwang, J. T., et al. (2015). Grb10: a critical regulator of insulin signaling and its implications in obesity and diabetes. *Obesity Reviews*, 16(3), 217-225.
